People · Operator
Named in public records as an officer, director or promoter · active 2015–2017 · Other, Other Health Care, Other Technology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Roxwood Medical, Inc. | — | Other | Series A | $10.4M | $97.8M | 2015 |
| InterVene, Inc. | — | Other Health Care | Series A | $9.6M | $11.8M | 2015 |
| CuraSeal Inc. | — | Other | Seed | $7.1M | $53.7M | 2015 |
| Maestro Interactive, Inc. | — | Other Technology | Series A | $5.8M | $161.8M | 2017 |
| Luma Therapeutics, Inc. | — | Pharma | Seed | $2.0M | $77.9M | 2017 |
| OneBreath, Inc. | — | Other Health Care | Pre-Seed | $348K | $10.7M | 2017 |
Evan Ng at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Evan Ng on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Ferrari | 1 | 15 |
| Jay Schmelter | 1 | 6 |
| Andrew Midler | 1 | 6 |
| Adam Berman | 1 | 4 |
| Doug Wall | 1 | 4 |
| Adam Fine | 1 | 4 |
| Kenneth Hayes | 1 | 3 |
| Fletcher Wilson | 1 | 3 |
| Joe Biller | 1 | 3 |
| Thomas Fogarty | 1 | 3 |
| Michael Wells | 1 | 3 |
| Terry Wall | 1 | 3 |
| Charles Davidson | 1 | 3 |
| Catherine L. Matthes | 1 | 3 |
| Steve Hochberg | 1 | 2 |
| Ari Evans | 1 | 2 |
| Michael Vorhaus | 1 | 2 |
| Mel Schatz | 1 | 2 |
| Jonathan Hera | 1 | 2 |
| John MacMahon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.